cysteine has been researched along with ro13-9904 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alajaji, M; Bowers, MS; Damaj, MI; Knackstedt, L | 1 |
| Narimani, S; Samadi, N | 1 |
| Kim, KS; Liu, W; Prakash, A; Zhang, C; Zhu, N | 1 |
3 other study(ies) available for cysteine and ro13-9904
| Article | Year |
|---|---|
Effects of the beta-lactam antibiotic ceftriaxone on nicotine withdrawal and nicotine-induced reinstatement of preference in mice.
Topics: Amino Acid Transport Systems; Animals; Anti-Bacterial Agents; Ceftriaxone; Conditioning, Psychological; Cysteine; Excitatory Amino Acid Transporter 2; Extinction, Psychological; Glutamic Acid; Male; Mice; Mice, Inbred ICR; Nicotine; Reinforcement, Psychology; Reward; Substance Withdrawal Syndrome; Tobacco Use Disorder | 2013 |
An ultrasensitive and selective method for the determination of Ceftriaxone using cysteine capped cadmium sulfide fluorescence quenched quantum dots as fluorescence probes.
Topics: Biosensing Techniques; Cadmium Compounds; Ceftriaxone; Cysteine; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Ions; Quantum Dots; Spectrometry, Fluorescence; Spectroscopy, Fourier Transform Infrared; Sulfides | 2016 |
Targeting E. coli invasion of the blood-brain barrier for investigating the pathogenesis and therapeutic development of E. coli meningitis.
Topics: Acetates; Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Ceftriaxone; Cells, Cultured; Cyclopropanes; Cysteine; Drug Therapy, Combination; Endothelial Cells; ErbB Receptors; Escherichia coli; Female; Gefitinib; Humans; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Male; Meningitis, Escherichia coli; Mice; Permeability; Phospholipases A2, Cytosolic; Quinolines; Sphingosine-1-Phosphate Receptors; Sulfides | 2020 |